STOCKWATCH
·
Pharmaceuticals
Investment10 Nov 2025, 08:01 pm

Span Divergent Ltd. to Sell Entire Investment in Inoperative Subsidiary Span Diagnostics LLP for INR 99,000

AI Summary

Span Divergent Limited has announced its intention to sell or transfer the entire investment in its non-functional subsidiary, Span Diagnostics LLP, for a consideration of INR 99,000. This decision follows shareholder approval dated September 26, 2024, and was approved by the board on November 10, 2025. The subsidiary has been inoperative since its inception. The sale is expected to be completed on November 10, 2025, and the buyers are Mr. Viral P Desai and Ms. Sujata V Desai, who do not belong to the promoter/promoter group of Span Divergent Limited.

Key Highlights

  • Span Divergent Limited to sell entire investment in Span Diagnostics LLP
  • Consideration for the sale is INR 99,000
  • The subsidiary, Span Diagnostics LLP, is inoperative since its inception
  • The sale is expected to be completed on November 10, 2025
  • The buyers are Mr. Viral P Desai and Ms. Sujata V Desai, not part of Span Divergent Limited's promoter group
SDL
Pharmaceuticals
Span Divergent Ltd-$

Price Impact